Stay updated on Pembrolizumab in Hypermutation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page and updated the site version to v3.4.1, replacing v3.4.0; these are administrative UI changes that do not affect study details, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:43:08.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' and 'Last Update Submitted that Met QC Criteria', along with a new site revision (v3.4.0). The previous indicators like 'No Results Posted' and related status text have been removed.
    Difference
    0.3%
    Check dated 2026-01-28T02:59:22.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4; no substantive updates to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:35:18.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.3, and the previous Revision: v3.3.2 and the HHS Vulnerability Disclosure text have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:14:20.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The changes update the Publications section wording to indicate that PubMed-listed publications are automatically populated from PubMed, and note the revision version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:39:36.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A government funding/status notice at the top of the page was removed. This change does not affect the study content, eligibility criteria, or results of the trial. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:23:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.